NUZ neurizon therapeutics limited

Ann: First Patient of Cohort 2 Dosed in MND Trial, page-70

  1. 3,301 Posts.
    lightbulb Created with Sketch. 1934
    I honestly think that management realise that without credible and material progress they cannot excite the market.

    They have done their dash with stories of the 'potentials' and 'discussions' over the years. Investors want to see real rubber on the road not more grandiose ideas and Roger on repeat.

    What can they sell right now. That we may have a good drug? Done to death, prove it or get off the pot. Wheres the phase 3 canine deal, have we managed to convince potential partners of the opportunity since they told us they didnt see the opportunity.

    NZ i agree with your sentiment i just think there is no story they can tell right now that will restore credibility other than real progress. We may be closing in. Lets see if Roger is the genius many here suppose.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
17.0¢
Change
0.005(3.03%)
Mkt cap ! $83.69M
Open High Low Value Volume
16.5¢ 17.0¢ 16.5¢ $70.91K 420.5K

Buyers (Bids)

No. Vol. Price($)
4 104900 16.5¢
 

Sellers (Offers)

Price($) Vol. No.
17.0¢ 186536 2
View Market Depth
Last trade - 15.35pm 14/07/2025 (20 minute delay) ?
NUZ (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.